11:44 AM
Login form
«  February 2020  »
Entries archive

My site

Main » Entries archive
ME NewsWire / BusinessWire

SINGAPORE - Wednesday, August 21st 2013

Heptagon (, a leading provider of intelligent micro imaging, sensing and light systems for smart devices, today announced it has shipped more than one billion units to OEM customers. The company, which is headquartered in Singapore, includes among its customers some of the largest makers of smart phones and tablets in the world.

"Our rapid growth results from a powerful combination of innovation and execution," said Christian Tang-Jespersen, Heptagon’s chief executive officer & president. "World-class R&D, along with a relentless focus on quality and a proven agility to move rapidly from white board to mass production have driven rapid market acceptance of our products. We’re even more excited about our future and shipping the next billion units."

Heptagon’s products are used in a wide variety of imaging, sensing and light applications that require miniaturization, precis ... Read more »
Views: 122 | Added by: africa-live | Date: 08.21.2013

Industry Leader Recognized for Service Excellence for Both Clients and Employees

LAS VEGAS - Tuesday, August 20th 2013 [ME NewsWire]

(BUSINESS WIRE) Rimini Street, Inc., the leading third-party maintenance and support provider for enterprise software, including SAP AG’s (NYSE:SAP) Business Suite and BusinessObjects software and Oracle Corporation’s (NYSE:ORCL) Siebel, PeopleSoft, JD Edwards, E-Business Suite, Oracle Database and Hyperion software, today announced that it was named the winner of three Stevie® Awards in the customer service, support and human resources categories of The 10th Annual International Business AwardsSM, demonstrating the Company’s commitment to providing service excellence for both its clients and employees. This is the second consecutive year that the Company has been recognized as a Stevie Award winner.

Rimini Street’s team of primary support engineers (PSEs) once again received a Steve Award, this year receiving the Gold Stevie awar ... Read more »
Views: 112 | Added by: africa-live | Date: 08.21.2013

NEW JERSEY - Tuesday, August 20th 2013 [ME NewsWire]

(BUSINESS WIRE)-- A clinical study to evaluate the prophylactic effect of non-invasive vagal nerve stimulation for the prevention of chronic migraine completed enrollment last week. The study, which is being sponsored by electroceutical healthcare company electroCore, involves 60 patients across six US sites1.

After an initial one month period, during which headache frequency data will be collected, the patients, all of whom experience migraine headaches on more than 15 daysper month, will be randomized into two groups. One group will use an active device and the other a sham device for a period of two months. All patients will then be provided with the active treatment device for a period of six months. Throughout the study, patients will record the number of headache days and the severity of the headaches experienced. The full results are expected in the second quarter of 2014.

This study, which is part of one ... Read more »
Views: 99 | Added by: uaeonlinenews | Date: 08.20.2013

ME NewsWire / BusinessWire

COLUMBUS, Ga. & LONDON - Monday, August 19th 2013

TSYS (NYSE: TSS), a leading global payments solution provider, and FICO® (NYSE: FICO), a leading analytics software company, have announced the integration of FICO’s latest version of its fraud management solution, FICO® Falcon® Fraud Manager 6 with TSYS’ licensed PRIME card and merchant management solution. This extension to TSYS’ global strategic alliance with FICO will enable TSYS to offer the Falcon Fraud Manager solution as a hosted service to its licensing clients around the globe.

TSYS and FICO’s integrated solution is being successfully utilised by EnterCard, a Nordic-based TSYS PRIME client since 1999. The integrated Falcon solution manages fraud by examining the behavioural aspects of cardholder activity, using advanced analytic models to provide real-time decisions. Combining best-in-class neural network models with merchant profiles, the solution even goes one s ... Read more »
Views: 115 | Added by: africa-live | Date: 08.19.2013

SANTA ANA, Calif. - Monday, August 19th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Irvine Scientific®, a global leader in Assisted Reproductive Technologies (ART), announced that they have received CE Mark approval for their Continuous Single Culture™ (CSCM) and Continuous Single Culture™ Complete (CSCM-C) products. The company will commence commercialization at centers across Europe immediately.

Both CSCM and CSCM-C (containing Human Serum Albumin) are embryo culture media used for fertilization and culture of embryos to day 3, or day 5/6 of embryo development. CSCM and CSCM-C are the only single-step culture media designed to be used in an uninterrupted culture system, without the need for medium renewal or dish change. Intended for laboratories who want to reduce stress on embryos while improving clinical results, the optimized formulation reduces embryo stress by eliminating the need to expose embryos to varying media environments, temperature and pH fluctuations. Irvin ... Read more »
Views: 91 | Added by: africa-live | Date: 08.19.2013

NEW YORK - Saturday, August 17th 2013 [ME NewsWire]

(BUSINESS WIRE) American International Group, Inc. (AIG) today announced that it is now offering globally up to $100 million in limits for Side A Directors and Officers (D&O) liability insurance.

This new capacity from AIG, combined with the insurer’s financial strength and claims handling experience, can facilitate the efficient resolution of severe and complex litigation. Companies can now meet their Side A needs by significantly reducing the number of insurance carriers and policy layers necessary for adequate coverage, creating a more efficient D&O insurance structure.

"Too often, settlements are delayed or even increased when customers wait for several insurance carriers to agree on the resolution of a D&O claim,” said Michael Smith, President of AIG Global Financial Lines. "AIG is pleased to provide our clients expanded capacity to build one tower to avoid multiple coverage positions from differe ... Read more »
Views: 126 | Added by: uaeonlinenews | Date: 08.18.2013 | Comments (0)

HIGH POINT, N.C. - Thursday, August 15th 2013 [ME NewsWire]

(BUSINESS WIRE)-- TransTech Pharma, Inc. announced today important clinical trial data for its new diabetes drug. TTP399, a novel, liver-selective glucokinase activator (GKA), demonstrated clinical evidence of normalizing HbA1c without inducing hypoglycemia in type 2 diabetic subjects on stable doses of metformin. TTP399 is the first liver-selective GKA that shows no GKA activation in the pancreas and does not interrupt the binding of glucokinase (GK) with the GK regulatory protein (GKRP).

TTP399 has completed a 6-week, multi-center, phase 2a study in type 2 diabetic subjects on stable doses of metformin. TTP399 treatment led to a reduction in HbA1c of 0.92 (p< 0.001) and 0.53 (p< 0.001) placebo-corrected. In addition, 100% of subjects on drug with a starting HbA1c baseline of 7.5% or less achieved the American Diabetes Association’s goal of reducing HbA1c values to 7% or less, and up to 85% of those subjec ... Read more »
Views: 152 | Added by: uaeonlinenews | Date: 08.17.2013

HONG KONG. - Friday, August 16th 2013 [ME NewsWire]

Rapid PC Plus transformation fueled by solid growth from PC and PC Plus businesses

    Ranked #1 PC maker in the world for the first time ever
    Ranked #3 supplier of smart-connected devices (smartphones, tablets and PCs) worldwide
    Pre-tax income of US$215 million and earnings of US$174 million
    Revenue of US$8.8 billion
    Basic EPS of 1.67 US cents, or 12.96 HK cents
    Net cash reserves of US$3.1 billion (as of June 30, 2013)

(BUSINESS WIRE) Lenovo Group today reported results for its first fiscal quarter ended June 30, 2013, with quarterly revenue of US$8.8 billion, a ten percent increase year-over-year. At the same time, Lenovo’s first quarter pre-tax income increased 16 percent year-over-year to US$215 million, while earnings grew 23 percent year-over-year to US$174 million, highlighting the Co ... Read more »
Views: 104 | Added by: uaeonlinenews | Date: 08.17.2013

Linagliptin demonstrated clinically important HbA1c reduction, safety and tolerability profile in elderly people with Type 2 Diabetes with inadequate glycaemic control

INGELHEIM, Germany & INDIANAPOLIS, US - Thursday, August 15th 2013 [ME NewsWire]

(BUSINESS WIRE)-- For Non-US and Non-UK Media

Data published in The Lancet showed that elderly people with Type 2 Diabetes (T2D) treated for 24 weeks with the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin, marketed by Boehringer Ingelheim and Eli Lilly and Company, experienced significant reductions in blood glucose levels (HbA1c) compared with those receiving placebo. In addition, the overall safety and tolerability profile of linagliptin was similar to placebo, with no significant difference in hypoglycaemia.1

"Elderly individuals comprise approximately 15% of people with Type 2 Diabetes2; however, few glucose-lowering agents have been investigated in this group. This evidence gap hinders clinical de ... Read more »
Views: 94 | Added by: uaeonlinenews | Date: 08.17.2013 | Comments (0)

Acquisition bolsters Quintiles’ small biopharma, oncology and medical device capabilities

RESEARCH TRIANGLE PARK, N.C - Thursday, August 15th 2013 [ME NewsWire]

(BUSINESS WIRE) To stay ahead of the diverse and evolving needs of its global customer base, Quintiles today announced it has signed an agreement to acquire Novella Clinical (Novella), a full-service clinical research organization (CRO) focused primarily on emerging oncology customers as well as those in the medical device and diagnostics sectors.

"The expertise and insight the Novella team brings will be a strong addition to our existing capabilities and help further differentiate Quintiles in an increasingly competitive marketplace,” said Paula Brown Stafford, President, Clinical Development at Quintiles. "Novella’s understanding of emerging companies, as well as our shared commitment to quality, customer service, and above all, the patients we ultimately serve, makes this acquisition a good fit for both ... Read more »
Views: 102 | Added by: africa-live | Date: 08.17.2013 | Comments (0)

« 1 2 ... 1338 1339 1340 1341 1342 ... 1443 1444 »